Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study
ConclusionThis study suggests that levels of anti-S antibodies can predict critical or fatal outcomes in COVID-19 pneumonia patients, regardless of vaccination. Whether anti-S Ab could guide risk assessment and vaccination boosting merits further evaluation.
Source: Infection - Category: Infectious Diseases Source Type: research
More News: Cancer & Oncology | Covid Vaccine | COVID-19 | Diabetes | Endocrinology | Hematology | Infectious Diseases | Pneomococcal Vaccine | Pneumonia | SARS | Study | Vaccines